4.2 Article

The burden of sinus disease in cystic fibrosis lung transplant recipients

Journal

TRANSPLANT INFECTIOUS DISEASE
Volume 20, Issue 5, Pages -

Publisher

WILEY
DOI: 10.1111/tid.12924

Keywords

airway colonization; chronic rhinosinusitis; cystic fibrosis; lung transplantation; sinus disease; upper airways

Funding

  1. European Respiratory Society [STRTF 2014-7178]

Ask authors/readers for more resources

IntroductionSinus disease (SD) in cystic fibrosis (CF) is a known risk factor for disease progression, the upper airways (UAW) being a site of primary colonization with Pseudomonas aeruginosa. UAW may function as reservoir for graft colonization after lung transplantation (LuTx), increasing risk of rejection. Aims of this study were to assess the burden of sinus disease in CF LuTx recipients, considering patient-reported symptoms, endoscopically documented signs and microbiological isolates, comparing colonization between upper and lower airways. MethodsA prospective, observational study was performed on consecutive CF LuTx recipients, recording history, symptoms, and management of SD. Nasal lavage (NL) was evaluated for UAW colonization, with nasal inspection during bronchoscopy and bronchoalveolar lavage (BAL) used to assess lower airways if clinically indicated. ResultsHundred and fifty-four patients were included. Symptoms of SD were reported in 96 (62%) individuals; 87 (56%) had prior sinus surgery. Only 8 (13%) of 60 individuals undergoing bronchoscopy presented completely normal findings of the nasal cavity. Thirty-six (60%) patients presented the same isolates on both NL and BAL. Polyps and mucosal alterations were significantly less frequently seen endoscopically in patients with normal flora in NL microbiology (respectively, 26% vs 70%, P=.003, and 35% vs 68%, P=.013). ConclusionsSymptoms of SD affected more than 60% of CF LuTx recipients. Nasal endoscopic inspection identified alterations in 55%. The majority of patients presented the same isolates both on NL and BAL performed on the same visit. These results strongly support a role of paranasal sinuses as reservoir for descending re-colonization of the lung graft.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study

Nikolaus Kneidinger, Matthias Hecker, Vasiliki Bessa, Ina Hettich, Alexandra Wald, Sabine Wege, Anna-Barbara Nolde, Maike Oldigs, Zulfiya Syunyaeva, Heinrike Wilkens, Jens Gottlieb

Summary: This study aims to assess the outcome and associated factors in lung transplant recipients during the Omicron era of COVID-19, and found that age and glomerular filtration rate < 30 ml/min/1.73m(2) were independent risk factors for severe or critical COVID-19.

INFECTION (2023)

Article Pediatrics

Combined multi-channel intraluminal impedance measurement and pHmetry in the detection of gastroesophageal reflux disease in children with cystic fibrosis

Emilia da Silva Goncalves, Jose Dirceu Ribeiro, Fernando Augusto Lima Marson, Ciro Garcia Montes, Antonio Fernando Ribeiro, Jochen Georg Mainz, Adyleia Aparecida Dalbo Contrera Toro, Juliana Helena Zamariola, Daniela Souza Paiva Borgli, Elizete Aparecida Lomazi, Maria de Fatima Correa Pimenta Servidoni

Summary: The prevalence of GERD in children with CF was assessed using multichannel intraluminal impedanciometry associated with pH monitoring (MIIpH) and compared with respiratory symptoms. It was found that MIIpH detected 30% more GERD patients than pHmetry.

JORNAL DE PEDIATRIA (2023)

Article Multidisciplinary Sciences

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

Valentino Bezzerri, Valentina Gentili, Martina Api, Alessia Finotti, Chiara Papi, Anna Tamanini, Christian Boni, Elena Baldisseri, Debora Olioso, Martina Duca, Erika Tedesco, Sara Leo, Monica Borgatti, Sonia Volpi, Paolo Pinton, Giulio Cabrini, Roberto Gambari, Francesco Blasi, Giuseppe Lippi, Alessandro Rimessi, Roberta Rizzo, Marco Cipolli

Summary: As an inherited disorder characterized by severe pulmonary disease, cystic fibrosis could be considered a comorbidity for coronavirus disease 2019. However, current clinical evidence suggests that cystic fibrosis may actually protect against SARS-CoV-2 infection. The expression of SARS-CoV-2 receptors in primary airway epithelial cells is regulated by the CFTR channel, and dysfunctional CFTR channels in cystic fibrosis cells result in reduced viral entry and replication.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Calcineurin-inhibitor free immunosuppression after lung transplantation - a single center case-control study in 51 patients converted to Mechanistic Target of Rapamycin (mTOR) inhibitors

Jens Gottlieb, Bettina Fischer, Jonas Schupp, Heiko Golpon

Summary: This study investigated the effectiveness of CNI-free immunosuppression using mTOR inhibitors in lung transplant recipients. The results showed that the 1-year survival rate was 36% in patients with malignancy who were converted to CNI-free immunosuppression, while the 1-year survival rate was 100% in other patients. Additionally, patients who received this immunosuppression showed improvement in glomerular filtration rate.

PLOS ONE (2023)

Article Medicine, General & Internal

Clinical Characteristics and Outcomes of Patients with Acute Respiratory Failure Due to SARS-CoV-2 Interstitial Pneumonia Treated with CPAP in a Medical Intermediate Care Setting: A Retrospective Observational Study on Comparison of Four Waves

Silvia Accordino, Ciro Canetta, Greta Bettini, Federica Corsico, Gabriele Ghigliazza, Laura Barbetta, Christian Folli, Valeria Savojardo, Francesco Blasi

Summary: The aim of this study was to compare the characteristics of COVID-19 patients admitted to a Medical Intermediate Care Unit for acute respiratory failure due to SARS-CoV-2 pneumonia throughout four pandemic waves. The results showed that COVID-19 patients have become progressively older and with more comorbidities, and non-survivors were older and more comorbid compared to patients transferred to the ICU. There was no statistical difference in in-hospital mortality, but the rate of ICU-transfers significantly decreased.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Respiratory System

Lung transplantation for COPD/pulmonary emphysema

Geert M. Verleden, Jens Gottlieb

EUROPEAN RESPIRATORY REVIEW (2023)

Review Infectious Diseases

New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA)

Susanna Esposito, Francesco Blasi, Nigel Curtis, Sheldon Kaplan, Tiziana Lazzarotto, Marianna Meschiari, Cristina Mussini, Maddalena Peghin, Carlos Rodrigo, Antonio Vena, Nicola Principi, Matteo Bassetti

Summary: This paper discusses the main characteristics and clinical use of new licenced anti-staphylococcal drugs. In vitro studies have shown that some new anti-staphylococcal antibiotics have better antimicrobial activity and more favorable pharmacokinetic properties and safety compared to currently available drugs. However, further research is needed before the problem of S. aureus resistance to antibiotics can be completely solved.

ANTIBIOTICS-BASEL (2023)

Article Biology

Bone Disease in Long-Term Lung Transplant Survivors

Giorgia Grassi, Elisa Cairoli, Lucrezia Maria Silvana Gentile, Iacopo Chiodini, Marta Zampogna, Alberto Ghielmetti, Letizia Corinna Morlacchi, Valeria Rossetti, Lorenzo Rosso, Ilaria Righi, Mario Nosotti, Maura Arosio, Francesco Blasi, Cristina Eller Vainicher

Summary: Based on our study, the skeletal outcomes in long-term survivors (>5 years) after lung transplantation were similar between patients with cystic fibrosis (CF) and those with non-cystic fibrosis (nCF), with a lower incidence of fractures compared to the first two years post-transplant. Bone mineral density and trabecular bone score remained stable after the second year post-transplant.

LIFE-BASEL (2023)

Article Cardiac & Cardiovascular Systems

A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant

Jens Gottlieb, Fernando Torres, Tarik Haddad, Gundeep Dhillon, Daniel F. Dilling, Christiane Knoop, Reinaldo Rampolla, Rajat Walia, Vivek Ahya, Romain Kessler, Marie Budev, Claus Neurohr, Allan R. Glanville, Robert Jordan, Danielle Porter, Matt McKevitt, Polina German, Ying Guo, Jason W. Chien, Timothy R. Watkins, Martin R. Zamora

Summary: This study evaluated the efficacy of the RSV fusion inhibitor presatovir in RSV-infected lung transplant recipients. The results showed that presatovir did not significantly improve nasal RSV load, symptoms, or lung function in lung transplant recipients.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Editorial Material Respiratory System

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?

Mario Cazzola, Paola Rogliani, Francesco Blasi

Summary: The complexity of COPD calls for the identification of patient groups with similar characteristics and needs. Different clinical phenotypes and endotypes have been studied, but a new taxonomic classification based on causes has been proposed. The tractable traits approach is a simpler method, but lacks validation through large randomized controlled trials. Despite its application following the GOLD strategy, there are challenges in identifying and prioritizing treatable traits.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2023)

Article Respiratory System

Management and outcome of obstructive airway complications after lung transplantation - a 12-year retrospective cohort study

Jens Gottlieb, Thomas Fuehner, Patrick Zardo

Summary: This study investigated the management and outcome of obstructive airway complications (OACs) after lung transplantation. The results showed that bilateral OACs impose a high burden on patients and are associated with early and late graft loss. Patients with bilateral OACs had reduced graft function and impaired quality of life.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2023)

Review Respiratory System

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia

Francesco Amati, Francesco Bindo, Anna Stainer, Andrea Gramegna, Marco Mantero, Mattia Nigro, Linda Bussini, Michele Bartoletti, Francesco Blasi, Stefano Aliberti

Summary: There has been a significant increase in the use of broad-spectrum antibiotics as empirical therapy for patients with community-acquired pneumonia (CAP) in the past 15 years. This is driven by evidence of an increased incidence of drug-resistant pathogens (DRP) in CAP patients, including MRSA and Pseudomonas aeruginosa. However, recent studies have shown that the incidence of DRP in CAP varies greatly depending on the local ecology, healthcare systems, and countries where the studies were conducted. Some studies have questioned the effectiveness of broad-spectrum antibiotic coverage in improving outcomes in CAP, citing increased costs, longer hospital stays, drug adverse events, and antibiotic resistance as potential drawbacks.

ADVANCES IN RESPIRATORY MEDICINE (2023)

Article Respiratory System

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis

Andrea Gramegna, Fabio Majo, Gianfranco Alicandro, Gloria Leonardi, Luca Cristiani, Francesco Amati, Martina Contarini, Stefano Aliberti, Alessandro Giovanni Fiocchi, Francesco Blasi

Summary: This study aims to identify potential determinants of heterogeneity in weight gain following 6-month ETI therapy. The baseline BMI and the presence of at least one CFTR residual function mutation were found to be the major determinants of weight gain heterogeneity. The results indicate that ETI is highly effective in improving weight gain in underweight CF patients.

RESPIRATORY RESEARCH (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Safety and Immunogenicity of the AntiCOVID19 Vaccines in a Cohort of Lung Transplant Recipients

L. Morlacchi, V. Rossetti, S. Uceda Renteria, I. Righi, F. Ceriotti, L. Rosso, F. Blasi

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Insights Into the Lung Microenvironment During Chronic Allograft Rejection: The Role of Bal-Evs in Rewiring Respiratory Cells Inflammatory Response

V. Vaira, A. Storaci, S. Franzi, M. Pitasi, F. Gentile, V. Musso, L. Morlacchl, V. Rossetti, F. Blasi, M. Nosotti, S. Ferrero, A. Palleschi

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

No Data Available